Worth reading
71In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the 27th Series Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment, mNAV, Minimum Exercise Price Adjustment and Exercise Suspension Clauses)
Intended allottee
EVO FUND (allottee at the time of issuance)
Existing Shares and Increase
—Rate of increase
1,274,171,340 shares1,281,283,624Shares
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise prices during June 2026 were ¥291, ¥295, ¥267, ¥254, ¥246, ¥235, ¥237, ¥243, ¥229, ¥224, ¥232, ¥260, ¥260, ¥255, ¥232, ¥235, ¥245, ¥232, ¥232 and ¥220. The stock price-linked adjustment clause and minimum exercise price clause apply. The minimum amount is Not disclosed.
Number of Stock Acquisition Rights
Total issued: 1,000,000 stock acquisition rights; unexercised at the end of the month preceding the relevant month: 947,300; unexercised at the end of the relevant month: 947,300
Basis for determining the amount to be paid
The exercise price was initially adjusted on 17 April 2026. Thereafter, it is adjusted on each trading day to the closing price on the immediately preceding trading day, or to the minimum exercise price if that closing price is below the minimum exercise price.
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
1 April 2026 issuance: 27th Series Stock Acquisition Rights allotted to EVO FUND (total issued: 1,000,000 stock acquisition rights)
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 27th Series Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment, mNAV, Minimum Exercise Price Adjustment and Exercise Suspension Clauses) |
| Intended allottee | EVO FUND (allottee at the time of issuance) |
| Total number of issued shares | 1,274,171,340 shares (number of listed shares as of the payment date for the issuance) → 1,281,283,624 shares (number of issued common shares as of 30 June 2026) |
| Basis for determining the amount to be paid | The exercise price was initially adjusted on 17 April 2026. Thereafter, it is adjusted on each trading day to the closing price on the immediately preceding trading day, or to the minimum exercise price if that closing price is below the minimum exercise price. |
| Exercise price | The exercise prices during June 2026 were ¥291, ¥295, ¥267, ¥254, ¥246, ¥235, ¥237, ¥243, ¥229, ¥224, ¥232, ¥260, ¥260, ¥255, ¥232, ¥235, ¥245, ¥232, ¥232 and ¥220. The stock price-linked adjustment clause and minimum exercise price clause apply. The minimum amount is Not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 1,000,000 stock acquisition rights; unexercised at the end of the month preceding the relevant month: 947,300; unexercised at the end of the relevant month: 947,300 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | 1 April 2026 issuance: 27th Series Stock Acquisition Rights allotted to EVO FUND (total issued: 1,000,000 stock acquisition rights) |
Items this document does not state (20)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company explained that 30 June 2026 was a record date and other applicable reference date for the common shares, and that the stock acquisition rights could not be exercised on the day before or on the record date itself for procedural reasons relating to the Japan Securities Depository Center. Accordingly, the exercise price was not adjusted during that period.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.